Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAH: Optimizing Malaria and HIV Treatment in Africa
NCT06967519Phase 4Recruiting
- Sponsor
- Yale University
- Start
- Dec 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether, lumefantrine, artesunate, amodiaquine in malaria, sponsored by Yale University. Started Dec 2025; status: recruiting.
02
Drugs
artemetherlumefantrineartesunateamodiaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT06967519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06967519.